Capstone Wealth Management Group (Pennsylvania)’s Astera Labs ALAB Stock Holding History

Capstone Wealth Management Group (Pennsylvania)’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Buy	+2,227	New	+$591K	0.38%	45

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capstone Wealth Management Group (Pennsylvania)'s ALAB Position: Q2 2026 in Review

Capstone Wealth Management Group (Pennsylvania) opened a new position in Astera Labs (ALAB) in Q2 2026: 2,227 shares worth $1.08M. The stake represents 0.38% of the portfolio and ranks #45 among its holdings.

982 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Capstone Wealth Management Group (Pennsylvania) held 2,227 shares of Astera Labs worth $1.08M as of Q2 2026.
Astera Labs was a new Capstone Wealth Management Group (Pennsylvania) position in Q2 2026.
Astera Labs made up 0.38% of Capstone Wealth Management Group (Pennsylvania)'s portfolio in Q2 2026, its #45 holding.
982 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Capstone Wealth Management Group (Pennsylvania)'s 13F filing for Q2 2026, filed 30 Jul 2026.